Delivery Order SPE2DB24D1107-SPE2DB25FZEZ5

Award Date 4/15/25
Potential Completion Date 4/16/25
Potential Value $16K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $13,853.92 firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The award is for the provision of TRELEGY ELLIPTA 200-62.5-25 60S, a prescription medication, with a period of performance through April 15, 2024. Amerisourcebergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) with DLA Troop Support Medical valued at up to...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of TRELEGY ELLIPTA 200-62.5-25 60S medication. The contract has a ceiling value of $17,816.27 and a performance period through May 6, 2025. The award is not designated as a set-aside contract, indicating open competition. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
This is a $5,003.77 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of TRELEGY ELLIPTA 100-62.5-25 60S, a prescription medication, to support federal healthcare programs. The award has a period of performance through February 7, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The award, with a ceiling value of $1,905.37, is for a delivery order to supply the medication Trelegy Ellipta 100-62.5-25 60s. The contract is a firm fixed-price, non-set-aside arrangement with a performance period ending on May 6, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp for the supply of TRELEGY ELLIPTA 100-62.5-25 60S, a pharmaceutical product. The award has a ceiling value of $8,482.11 and is a firm fixed-price contract with a completion date of September 16, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between the DLA Troop Support Medical and AmerisourceBergen, valued at up to $999,999,999 through...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Trelegy Ellipta 100-62.5-25 60s medication. The award has a ceiling value of $29,568.11 and an ultimate completion date of September 30, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, which allows the agency to efficiently procure...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of TRELEGY ELLIPTA 200-62.5-25 60S, a pharmaceutical product, with a ceiling value of $41,502.81 and a period of performance ending on March 13, 2025. The contract is a Firm Fixed Price Delivery Order placed under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of TRELEGY ELLIPTA 200-62.5-25 60S medication. The contract, valued at $10,357.58, has an ultimate completion date of April 20, 2023. The award is not associated with a set-aside program. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of TRELEGY ELLIPTA 200-62.5-25 60S, a pharmaceutical product. The contract has a ceiling value of $5,650.67 and a period of performance ending on September 13, 2024. It is a firm fixed-price contract type. AmerisourceBergen, a major pharmaceutical distributor, is the prime contractor for this award, which is not subject to any set-aside requirements. The contract is part of a...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Trelegy Ellipta 100-62.5-25 60s medication. The contract has a ceiling value of $4,057.77 and a period of performance through April 21, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with DLA Troop Support Medical, valued at $999,999,999.00, which provides a...
  • SPE2DB24D1107
    Indefinite Delivery Contract
  • SPE2DB24D1107-SPE2DB25FZEZ5
    Delivery Order

This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of the medication TRELEGY ELLIPTA 100-62.5-25 60S. The contract has a ceiling value of $15,526.81 and a performance period ending on April 16, 2025.

Amerisourcebergen Drug Corp is the prime contractor for this award, which is not set-aside. The company holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, that serves as a comprehensive global pharmaceutical support vehicle through December 2026. This delivery order is likely part of the company's broader support for military and government healthcare programs through the IDC.

Generated 7/15/25, 3:17 PM